Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1993;24:1945-1950

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilpatrick, T. J.
Right arrow Articles by Dauer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilpatrick, T. J.
Right arrow Articles by Dauer, R. J.

Stroke, Vol 24, 1945-1950, Copyright © 1993 by American Heart Association


ARTICLES

Hematologic abnormalities occur in both cortical and lacunar infarction

TJ Kilpatrick, Z Matkovic, SM Davis, CM McGrath and RJ Dauer
Department of Neurology, Royal Melbourne Hospital, Victoria, Australia.

BACKGROUND AND PURPOSE: Primary hematologic abnormalities are a rare but established cause of ischemic stroke. In addition, activation of hemostatic parameters is often present during the acute phase of stroke. However, it is uncertain whether these abnormalities occur in both cortical and lacunar infarction; this study aimed to further assess this issue. METHODS: Hematologic parameters (prothrombin, activated partial thromboplastin, thrombin clotting, and euglobulin lysis times; and fibrinogen, fibrinopeptide A, antithrombin III, protein C, protein S, and plasminogen levels) were measured in 19 patients within 48 hours of the onset of acute cerebral infarction. These patients included 10 with cortical infarcts and 9 with lacunar infarcts, as determined by standard clinical and radiological criteria. RESULTS: Five patients with lacunar infarction and 7 patients with cortical infarction demonstrated raised fibrinopeptide A levels, indicating enhanced thrombin activity. Fibrinolysis, assessed by the euglobulin lysis time, was impaired in 6 of 9 patients with lacunar infarction and in 2 of 10 patients with cortical infarction. Lupus anticoagulants were detected in 3 patients with lacunar infarction and in 1 patient with cortical infarction. Three patients in each group displayed decreased antithrombin III function, and 1 patient with a lacunar infarction had a low protein C level. CONCLUSIONS: Primary hematologic disorders and secondary hemostatic derangements may occur in patients with either cortical or lacunar infarction.


This article has been cited by other articles:


Home page
StrokeHome page
J. Jannes, M. A. Hamilton-Bruce, L. Pilotto, B. J. Smith, C. G. Mullighan, P. G. Bardy, and S. A. Koblar
Tissue Plasminogen Activator -7351C/T Enhancer Polymorphism Is a Risk Factor for Lacunar Stroke
Stroke, May 1, 2004; 35(5): 1090 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Tomimoto, I. Akiguchi, H. Wakita, A. Osaki, M. Hayashi, and Y. Yamamoto
Coagulation Activation in Patients With Binswanger Disease
Arch Neurol, September 1, 1999; 56(9): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. T. Longstreth Jr, C. Bernick, T. A. Manolio, N. Bryan, C. A. Jungreis, T. R. Price, and for the Cardiovascular Health Study Collaborative
Lacunar Infarcts Defined by Magnetic Resonance Imaging of 3660 Elderly People: The Cardiovascular Health Study
Arch Neurol, September 1, 1998; 55(9): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
A. Roden-Jullig, M. Britton, and J. Svensson
Antithrombin-III Activity and the Efficacy of Heparin in Progressing Ischemic Stroke
Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 129 - 132.
[Abstract] [PDF]